Dr. Jay Paul Granat, PHD LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1060 Main Street, Suite 307, River Edge, NJ 07661 Phone: 201-342-3663 Fax: 201-342-2258 |
Dr. Alan Gettis, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 117 Kinderkamack Rd, River Edge, NJ 07661 Phone: 201-488-1808 Fax: 201-488-3096 |
Dr. Shira Deborah Donath, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1060 Main St Ste 306, River Edge, NJ 07661 Phone: 201-614-4580 |
News Archive
A recent study led by the researchers from Johns Hopkins University reveals multiple and diverse introductions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States National Capital Region during the initial phase of coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the medRxiv* preprint server.
The Food and Drug Administration has approved a new image analysis system designed to help radiologists review computed tomography (CT) images of the chest to aid in the detection of solid nodules in the lungs.
Researchers at the University of Pennsylvania School of Medicine and collaborators are using minute, naturally occurring proteins called zinc fingers to engineer T cells to one day treat AIDS in humans.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
› Verified 4 days ago